Literature DB >> 21129927

Management of Gram-negative and fungal endocarditis.

Emanuele Durante-Mangoni1, Marie-Françoise Tripodi, Rosina Albisinni, Riccardo Utili.   

Abstract

Infective endocarditis is infrequently caused by Gram-negative bacteria or fungi. Gram-negative organisms are responsible for <4% of cases, whilst fungal endocarditis accounts for <1.5% of culture-positive cases worldwide. Endocarditis due to Gram-negative organisms or fungi is a rare but severe disease. It often has a nosocomial origin, is caused by virulent and often resistant organisms and presents a high rate of complications and high mortality. In this article we present the most recent literature data and address the current management of Gram-negative and fungal infective endocarditis. We also discuss the major challenges of antimicrobial treatment and discuss some issues related to surgical decision-making in difficult-to-manage cases. We finally present our centre's experience with Gram-negative infective endocarditis, with a special focus on the demanding issues that the management of these complex and severely ill patients raise.
Copyright © 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129927     DOI: 10.1016/j.ijantimicag.2010.11.012

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  5 in total

1.  Community-acquired multidrug-resistant Gram-negative bacterial infective endocarditis.

Authors:  Sowjanya Naha; Kushal Naha; Vasudev Acharya; H Manjunath Hande; G Vivek
Journal:  BMJ Case Rep       Date:  2014-08-05

2.  Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort.

Authors:  Marco Falcone; Giusy Tiseo; Emanuele Durante-Mangoni; Veronica Ravasio; Francesco Barbaro; Maria Paola Ursi; Maria Bruna Pasticci; Matteo Bassetti; Paolo Grossi; Mario Venditti; Marco Rizzi
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

3.  Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.

Authors:  Juan Hu; Yong-Hong Xiao; Yi Zheng; Yang-Xiao Lai; Xue-Ling Fang; Qiang Fang
Journal:  Eur J Clin Pharmacol       Date:  2020-04-30       Impact factor: 2.953

4.  Fatal Vitamin K-Dependent Coagulopathy Associated with Cefoperazone/Sulbactam: A Case Report.

Authors:  Huan-Rong Hu
Journal:  Drug Saf Case Rep       Date:  2019-06-14

5.  Epidemiology and the prognosis of healthcare-associated infective endocarditis in China: the significance of non-nosocomial acquisition.

Authors:  Feifei Yang; Bingyan Zhang; Jie Yu; Lingyun Shao; Pu Zhou; Liping Zhu; Shu Chen; Wenhong Zhang; Xinhua Weng; Jiming Zhang; Yuxian Huang
Journal:  Emerg Microbes Infect       Date:  2015-07-01       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.